BackColgate-Palmolive Overview
Colgate-Palmolive Co.

Colgate-Palmolive Target Price

Analysts' average 12-month price target for Colgate-Palmolive is $100.

Get informed when a big investor buys or sells

+ Follow

Share Price

$90.09

Average Target Price

$101.0012.1% upside

8 analysts in the last 4 months

High: $109 | Low: $95

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-03RBC CapitalNik Modi$10415.4% upsideOpen
2026-08-03Deutsche Bank$10112.1% upsideOpen
2026-08-03Morgan Stanley$10415.4% upsideOpen
2026-08-03UBS$10921% upsideOpen
2026-07-08Wells FargoChris Carey$955.5% upsideOpen
2026-06-11BernsteinCristian Rios$966.6% upsideOpen
2026-05-04UBS$10011% upsideOpen
2026-05-04Deutsche BankSteve Powers$999.9% upsideOpen
2026-04-21Redburn Partners$10011% upsideOpen
2026-04-14BarclaysLauren Lieberman$7912.3% downsideOpen
2026-04-09RBC Capital$10213.2% upsideOpen
2026-04-08Piper Sandler$922.1% upsideOpen
2026-04-08Wells FargoChris Carey$922.1% upsideOpen
2026-02-20Goldman SachsBonnie Herzog$10011% upsideOpen
2026-02-13Redburn Partners$933.2% upsideOpen
2026-02-03BarclaysLauren Lieberman$882.3% downsideOpen
2026-02-02Morgan StanleyDara Mohsenian$10011% upsideOpen
2026-02-01Wells Fargo$944.3% upsideOpen
2026-01-31Goldman SachsBonnie Herzog$944.3% upsideOpen
2026-01-30Piper Sandler$966.6% upsideOpen
2026-01-16BarclaysLauren Lieberman$837.9% downsideOpen
2026-01-14UBSPeter Grom$933.2% upsideOpen
2026-01-13Wells Fargo$864.5% downsideOpen
2026-01-06Piper Sandler$882.3% downsideOpen
2025-12-16Jefferies$855.6% downsideOpen
2025-12-09RBC Capital$882.3% downsideOpen
2025-11-03Evercore ISIRobert Ottenstein$944.3% upsideOpen
2025-11-03Morgan StanleyDara Mohsenian$873.4% downsideOpen
2025-10-10Deutsche Bank$864.5% downsideOpen
2025-10-08UBS$922.1% upsideOpen
2025-10-03Piper Sandler$846.8% downsideOpen
2025-10-01BarclaysLauren Lieberman$829% downsideOpen
2025-08-04Morgan Stanley$966.6% upsideOpen
2025-03-27Barclays$891.2% downsideOpen
2024-09-23Piper SandlerKorinne Wolfmeyer$12134.3% upsideOpen
2024-09-16Wells FargoChris Carey$10011% upsideOpen
2024-07-22Stifel NicolausMark Astrachan$10516.6% upsideOpen
2024-05-28Morgan StanleyDara Mohsenian$10314.3% upsideOpen
2024-05-15Argus ResearchChris Graja$10718.8% upsideOpen
2024-04-29Deutsche BankSteve Powers$988.8% upsideOpen
2024-04-29Stifel NicolausMark Astrachan$955.5% upsideOpen
2024-04-10Stifel NicolausMark Astrachan$944.3% upsideOpen
2024-04-08Evercore ISIRobert Ottenstein$966.6% upsideOpen
2024-01-29Raymond JamesOlivia Tong$911% upsideOpen
2023-07-28Wells FargoChris Casey$8110.1% downsideOpen
2023-01-13J.P. Morgan$864.5% downsideOpen
2023-01-03Barclays$8011.2% downsideOpen
2022-12-06Deutsche Bank$873.4% downsideOpen
2022-10-18Credit SuisseKaumil Gajrawala$855.6% downsideOpen
2022-10-03Wells Fargo$7516.7% downsideOpen

Colgate-Palmolive (CL) FAQ

Colgate-Palmolive's target price stands at $100. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $100 for CL implies 12.1% upside versus today's price ($90.09). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Colgate-Palmolive's target price evolved across reporting periods, while the comparison chart places CL next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Consumer Staples, target price is commonly used to spot outliers. Colgate-Palmolive's reading of $100 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.